论文部分内容阅读
Daily 20-mg and once-weekly 56.5-mg teriparatide(parathyroid hormone 1–34) treatment regimens increase bone mineral density(BMD) and prevent fractures, but changes in bone turnover markers differ between the two regimens. The aim of the present study was